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All hypertensive 
patients can 
potentially 
benefi t from 
lifestyle changes, 
including weight 
reduction, 
physical activity, 
the DASH diet, 
and limited 
alcohol use.Evidence summary
Th e prevalence of hypertension is increas-
ing. Twenty-seven percent of adult Americans 
are hypertensive; 31% have prehypertension 
(TABLE).1 Among adults older than 50 years, 
the risk of developing high blood pressure ap-
proaches 90% if they live to age 80 or older.2 
Cardiovascular risk rises along with blood 
pressure readings. Blood pressure values in 
the range of 130/85 to 139/89 mm Hg are as-
sociated with a more than 2-fold increase in 
cardiovascular disease risk compared with 
values below 120/80 mm Hg.2 
Even small reductions in blood pressure, 
when applied to the population as a whole, 
produce signifi cant improvements in patient-
oriented outcomes. A drop in systolic blood 
pressure of 3 mm Hg can decrease stroke mor-
tality by 8% and coronary artery disease by 5%.2 
Lifestyle interventions 
for treating hypertension
Lifestyle interventions for hypertensive pa-
tients include:
•   Striving to maintain or achieve an ideal 
body weight (body mass index of 18-25).2 
However, even modest weight reduc-
tions in overweight and obese hyperten-
sive patients signifi cantly lower blood 
pressure and overall cardiovascular risk. 
A 10-kg decrease in body weight can 
lower systolic blood pressure by 5 to 20 
mm Hg.2 
•   Adopting the DASH diet.1 Consuming a 
diet rich in fruits, vegetables, and low-
fat dairy products and limiting saturated 
and total fat intake can reduce systolic 
blood pressure by 2 to 8 mm Hg. 
•   Engaging in regular physical activity for 
at least 30 minutes most days of the week. 
Th is regimen has been shown to decrease 
systolic blood pressure by 4 to 9 mm Hg.2
•   Limiting daily alcohol intake, if the pa-
tient drinks, to 2 servings for men and 1 
for women and lower-weight individu-
als.2 Restricting alcohol consumption 
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A  it depends on the patient’s   risk factors, physical condition, 
and preferences. All hypertensive patients 
can potentially benefi t from lifestyle inter-
ventions, including weight reduction, aero-
bic physical activity, the dietary approaches 
to stop hypertension (DASH) diet, and mod-
eration of alcohol use (strength of recom-
mendation [SOR]: A, systematic reviews). 
Although lifestyle interventions  are ef-
fective for some patients, they haven’t been 
proven to provide long-term control and 
don’t lower blood pressure as much as med-
ications (SOR: B, systematic review of incon-
sistent randomized controlled trial [RCT]). 
For specifi c high-risk patients, pharmaco-
logic therapy is recommended at the time of 
diagnosis (SOR: C, expert opinion).
When considering lifestyle changes 
and medication, it’s important to assess 
patient preferences as well as overall car-
diovascular risks, presence of target organ 
damage, and clinical cardiovascular dis-
ease, because lifestyle modifi cation and 
medication can both aff ect quality of life 
(SOR: C, expert opinion). 
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Although 
lifestyle 
interventions 
work for some 
patients, they 
haven’t been 
shown to 
provide long-
term control 
and don’t lower 
blood pressure 
as much as 
medication.
may lower systolic blood pressure by 2 to 
4 mm Hg. 
Randomized controlled trials have con-
sistently demonstrated that patients who 
combine multiple lifestyle interventions 
achieve the greatest benefi ts.3-5 Success obvi-
ously requires patient motivation. Health care 
providers need to continually assess motiva-
tion and encourage adherence.
Most patients need medication, too
Lifestyle changes alone haven’t been shown 
to achieve the same long-term reductions 
in blood pressure as medication.5 Although 
some motivated patients can control their 
blood pressure solely by adjusting their life-
style, few succeed in reaching and maintain-
ing blood pressure goals. Continued attention 
to lifestyle should be encouraged both to 
control blood pressure and reduce overall 
cardiovascular risk, but most patients with hy-
pertension need medication. 
Th e Seventh Report of the Joint National 
Committee on Prevention, Detection, Evalu-
ation, and Treatment of High Blood Pressure 
(JNC7) doesn’t specify whether to off er a trial 
of therapeutic lifestyle change before starting 
medication.2 Clinicians should negotiate inter-
ventions based on each patient’s preferences, 
risk factors, and the presence or absence of clin-
ical cardiovascular disease or target organ dam-
age. Lifestyle changes and medication both can 
aff ect quality of life. Immediate pharmacologic 
treatment with 2 medications has been recom-
mended in addition to lifestyle interventions for 
patients with stage 2 hypertension (TABLE).2
Recommendations
Th e European Society of Hypertension pro-
vides recommendations for the duration of life-
style interventions before trying medication. 
Th e recommendations are based on a complex 
scheme of overall cardiovascular risk assess-
ment that takes into account traditional Fram-
ingham risks and other factors (such as obesity, 
C-reactive protein, and micro albuminuria), as 
well as the stage of hypertension.6 Th e Society 
recommends starting drug therapy immedi-
ately in people with blood pressure >180/110 
mm Hg. Th is blood pressure threshold drops 
in patients with increasing numbers of risk fac-
tors. For patients with lower, but still elevated, 
blood pressure, the recommendations call for 
TABLE 
JNC7 classifi cations of blood pressure in adults
Blood pressure classifi cation Blood pressure (mm Hg) Recommended follow-up
Normal Systolic <120       
AND
diastolic <80
2 y
Prehypertension Systolic 120-139 
OR
diastolic 80-89
1 y
Stage 1 hypertension Systolic 140-159 
OR
diastolic 90-99
2 mo
Stage 2 hypertension Systolic ≥160
OR
diastolic ≥100
1 mo*
JNC7, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure.
*For people with higher values (>180/110 mm Hg), evaluate and treat immediately or within 1 week, depending on clinical 
situation.
Source: Chobanian AV, et al. Hypertension. 2003.2
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“lifestyle changes for several months, then drug 
treatment if BP is uncontrolled.”
For patients with diabetes, the Ameri-
can Diabetes Association (ADA) recommends 
a blood pressure goal of <130/80 mm Hg 
and drug therapy in addition to lifestyle and be-
havioral therapy for patients with systolic blood 
pressure ≥140 mm Hg or diastolic blood pres-
sure ≥90 mm Hg.7 Like the JNC7, the ADA notes 
that a combination of medications is often re-
quired to achieve blood pressure targets. Th e 
ADA recommendations also state that patients 
with diabetes and a systolic blood pressure of 
130 to 139 mm Hg or a diastolic blood pressure 
of 80 to 89 mm Hg should pursue lifestyle and 
behavioral interventions alone for a maximum 
of 3 months, then start drug therapy if they 
don’t achieve their blood pressure goals.
Th e American Heart Association and 
American College of Cardiology off er evi-
dence-based guidelines for secondary pre-
vention in patients with atherosclerosis.8 Th ey 
set blood pressure goals of <140/90 mm Hg for 
all patients and <130/80 mm Hg for patients 
with diabetes or chronic kidney disease. All 
patients are encouraged to initiate or main-
tain lifestyle modifi cations. If a patient’s blood 
pressure is ≥140/90 mm Hg (>130/80 mm Hg 
for patients with chronic kidney disease or 
diabetes), medications should be titrated to 
goal, beginning with beta-blockers or angio-
tensin-converting enzyme inhibitors.            JFP
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